Back

Association between NT-proBNP changes and clinical outcomes in paediatric patients with heart failure due to systemic left ventricular systolic dysfunction: Insights from PANORAMA-HF

23 May 2023 (09:12 - 09:21)
Organised by: Logo
Congress Presentation Part of: Biomarkers definning pathophysiology and prognosis Biomarkers HFA Premium Access Heart Failure 2023 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Robert Shaddy

Children Hospital, Los Angeles (United States of America)

6 More presentations in this session

Presentation thumbnail
Cardiac Troponin-T and heart failure risk in individuals with low natriuretic peptide levels and obesity: results from the PREVEND study
Doctor N. Suthahar (Rotterdam, NL)
Abstract Slides Video
Presentation thumbnail
Soluble transferrin receptor as a marker of tissue iron deficiency: impact on clinical outcomes in patients with heart failure without systemic iron deficiency or anaemia
Miss M. Ras Jimenez (Hospitalet De Llobregat, ES)
Abstract Slides Video
Presentation thumbnail
Activation of neutrophil extracellular trap formation in patients with heart failure and a preserved ejection fraction
Mr B. Van Essen (Groningen, NL)
Abstract Slides Video
Presentation thumbnail
Combined post- and pre-capillary pulmonary hypertension in heart failure is associated with increased levels of biomarkers of fibrosis, vasoconstriction and angiogenesis
Professor A. Roussoulieres (Brussels, BE)
Abstract Slides Video
Presentation thumbnail
Transcriptomic profiling of circulating extracellular vesicles identifies UBALD2 as a novel biomarker of cardiorenal disease
Miss B. Losada Fuentenebro (Pamplona, ES)
Abstract Slides Video

Access the full session

Session thumbnail
Biomarkers definning pathophysiology and prognosis
Video

The Event

Event poster

Heart Failure 2023

23 May 2023 09:12 CET
You may be interested in
thumbnail
Congress Session
Biomarkers definning pathophysiology and prognosis
thumbnail
Congress Presentation
Outcomes and effects of sacubitril/valsartan according to NT-proBNP level in patients with heart failure: a patient-level pooled analysis of the PARADIGM-HF and PARAGON-HF trials
thumbnail
Congress Session
Biomarkers to guide the treatment of heart failure: where are we going?

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources